ReviewCancers2021

Resistance Mechanisms to Combined CDK4/6 Inhibitors and Endocrine Therapy in ER+/HER2- Advanced Breast Cancer: Biomarkers and Potential Novel Treatment Strategies.

Abeer J Al-Qasem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.